A statement from the company said that one person fell ill during the test, after which we have decided to stay the trial. The statement said that this is a routine interruption, as not much information has yet been received about the illness of the person involved in the test. The test will be carried forward only after reviewing it.
According to a report by the health news website State News, AstraZeneca has banned the Corona vaccine trial for safety reasons. The decision was taken on behalf of the company because it was having serious adverse effects on a participant in the late phase of the trial. The vaccine, which has been banned, was believed to be an effective weapon in fighting Corona.
State News quoted a statement from a spokesperson for AstraZeneca that the standard review process prohibited vaccination to allow for the review of safety data. The study is testing the Kovid-19 vaccine being developed by AstraZeneca and University of Oxford researchers at various sites. This also includes testing being conducted in the United Kingdom, where adverse effects of the vaccine have been reported.
Also read: Trump said, Kovid-19 vaccine may be ready by October
According to the State News, detailed information on what the case was and when the adverse reaction to the vaccine was reported could not be known. However, the participants on which the vaccine was being tested will soon recover.
The report said, the ban on vaccine testing has affected other AstraZeneca vaccine trials. It has also affected clinical trials being carried out by other vaccine manufacturers. Now all of them will also be looking for such resolutions so that the proper effect of the vaccine can be understood.
The statement from the spokesperson for AstraZeneca states that large trials will coincidentally have the disease, but it should be reviewed independently to be carefully examined. The report stated that serious adverse reactions vary and may include issues that may include hospitalization, dangerous illness, and even death.
As of now, AstraZeneca has not commented on it yet. However, nine major US and European vaccine developers on Tuesday resolved to maintain scientific safety and efficacy standards for their experimental vaccines, despite the exigency to control the corona virus epidemic.